Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor

NCT00523809 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Slow accrual.

Conditions

Breast Cancer
Ovarian Cancer

Interventions

DRUG: Bevacizumab
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
DRUG: Fludarabine
DRUG: Melphalan
DRUG: Thymoglobulin

Sponsor

M.D. Anderson Cancer Center